Steven C. Kao

Sydney, NSW 2050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

Integrated cellular, proteomic and metabolomic profiling of immune-related adverse events in non-small cell lung cancer.

Integrated cellular, proteomic and metabolomic profiling of immune-related adverse events in non-small cell lung cancer.

Journal: Frontiers in immunology

Published: June 16, 2026

Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1).

Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 25, 2026

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

Journal: Diagnostics (Basel, Switzerland)

Published: March 03, 2026

Mass Cytometry Workflow to Achieve High-Dimensional Immunophenotyping in Resource-Limited or Decentralized Environments.

Mass Cytometry Workflow to Achieve High-Dimensional Immunophenotyping in Resource-Limited or Decentralized Environments.

Journal: Current protocols

Published: February 28, 2026

A Mass Cytometry-Based Blood Cell Phenotyping Workflow Enabling Inclusion of Resource-Limited and Rural Sites in Immune System Studies.

A Mass Cytometry-Based Blood Cell Phenotyping Workflow Enabling Inclusion of Resource-Limited and Rural Sites in Immune System Studies.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: December 14, 2025

Advanced Thymic Carcinoma Responds to Venetoclax and Azacitidine.

Advanced Thymic Carcinoma Responds to Venetoclax and Azacitidine.

Journal: Clinical lung cancer

Published: October 30, 2025

Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis.

Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 29, 2025

Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy.

Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy.

Journal: Clinical and translational radiation oncology

Published: October 21, 2025

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models.

Validation of chemoresistance phenotypes in pleural mesothelioma across 2D, 3D, and in vivo models.

Journal: Scientific reports

Published: September 19, 2025

Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancer.

Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancer.

Journal: Frontiers in oncology

Published: August 21, 2025

Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA).

Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA).

Journal: JTO clinical and research reports

Published: June 06, 2025

Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations.

Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 30, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026